Diabetes Complications Lecture Series: Amputation Prevention

Medical education program focused on preventing ulcers, healing chronic wounds, and avoiding amputations. Each event consists of 2.0 in-person CME/CNE accredited lectures that update health care professionals on new protocols, tools, and therapies to address the challenges of these costly and burdensome lower extremity diabetes complications.


2.0 CME/CNE Credits per event – AMA PRA Category 1 Credit

Monday, October 21, 2019 – 6:00PM – 8:30PM (Registration Open)

February 10, 2020 – 6:00PM – 8:30PM

April 20, 2020 – 6:00PM – 8:30PM

Apella, Alexandria Center for Life Science, 450 East 29th Street, New York, NY 10016


Free Registration



More than 425 million adults globally[1], and 30.3 million Americans[2], are burdened with diabetes. Patients who suffer from diabetes have a 15–25% chance of developing a chronic wound, including foot, venous and pressure ulcers.[3] Within diabetes populations, the prevalence of diabetic foot ulcers (DFUs), occurring beneath the ankle, is 6.3% globally, and 13% in North America.[4]

Those affected by DFUs and other chronic wounds are at increased risk for lower extremity vascular issues, notably peripheral arterial disease (PAD) that affects 50% of DFU patients[5]. 25% of PAD patients progress towards critical limb ischemia (CLI) and are at high risk of amputation.[6] Furthermore, diabetes is an independent predictor of recurrent deep vein thrombosis (DVT) a significant risk factor for venous leg ulcers (VLU), occurring between the knee and ankle[7].

In conclusion, there is a need for healthcare professionals to properly address diabetes patient ulceration risk factors, promote wound healing, and intervene on ischemic wounds in order to prevent amputations. Several studies have concluded that 85% of amputations are preceded by ulcers.[8]


  • Update the scientific knowledge of providers managing diabetes patients at risk of ulceration, non-healing wounds, and ischemic wounds
  • Present clinical evidence on strategies for ulcer prevention, wound healing, and amputation prevention
  • Engage providers through interactive Q&A and hands-on experience
  • Learning Objectives

  • Examine clinical evidence that influences the understanding and standards of ulcer prevention, wound care, and vascular surgery
  • Recognize factors that affect ulceration, wound healing progress, and vascular surgery outcomes
  • Practice evidence-based medicine in making decisions on a course of therapy
  • Identify clinical scenarios in which emerging wound treatment modalities would be appropriately applied
  • October Speakers & Topics

  • Considerations for the Role of Tissue Biopsy in Chronic Wounds
  • Bryan Markinson, DPM, Mount Sinai School of Medicine

  • Preventing Diabetic Foot Amputation with Oxygen Therapy
  • Alisha Oropallo, MD, Northwell Health

    February Topics

  • Endovascular or Open Revascularization for Critical Limb Ischemia
  • Debridement & Antimicrobials

    April Topics

  • Deep Vein Thrombosis & Ulceration Prevention
  • Negative Pressure Wound Therapy for Venous Ulcers

    Target Audience

  • Physicians
  • Surgeons
  • Nurses
  • Related Wound Care and Vascular Providers
  • Residents/Fellows


    [1] IDF Diabetes Atlas Eight Edition.” International Diabetes Federation, www.idf.org/aboutdiabetes/what-is-diabetes/facts figures.html

    [2] “Statistics About Diabetes.” American Diabetes Association, www.diabetes.org/resources/statistics/statistics-about-diabetes

    [3]Chronic wound infection: facts and controversies. Siddiqui AR, Bernstein JM Clin Dermatol. 2010 Sep-Oct; 28(5):519-26.

    [4] Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis.Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y Ann Med. 2017 Mar; 49(2):106-116.

    [5] Peripheral arterial disease in diabetes–a review. Jude EB, Eleftheriadou I, Tentolouris N Diabet Med. 2010 Jan; 27(1):4-14.

     [6] Andreozzi GM, Martini R. The fate of the claudicant limb. European Heart Journal-Supplements 2002; 4: 41–45. 

    [7]Piazza, Gregory, et al. “Venous Thromboembolism in Patients with Diabetes Mellitus.” The American Journal of Medicine, U.S. National Library of Medicine, July 2012, www.ncbi.nlm.nih.gov/pmc/articles/PMC3424058

    [8] Lower extremity amputations–a review of global variability in incidence. Moxey PW, Gogalniceanu P, Hinchliffe RJ, Loftus IM, Jones KJ, Thompson MM, Holt PJ Diabet Med. 2011 Oct; 28(10):1144-53.